Ocumension Therapeutics (HKG:1477)

Hong Kong · Delayed Price · Currency is HKD

6.93

+0.23 (3.43%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Discovering, Developing and Commercialising Ophthalmic Therapies	417.31M	246.37M	158.96M	56.15M	13.10M
Discovering, Developing and Commercialising Ophthalmic Therapies Growth	69.38%	54.99%	183.11%	328.73%	6792.63%
Total	417.31M	246.37M	158.96M	56.15M	13.10M
Total Growth	69.38%	54.99%	183.11%	328.73%	6792.63%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
People's Republic of China	417.31M	246.37M	158.96M	56.15M	13.10M
People's Republic of China Growth	69.38%	54.99%	183.11%	328.73%	6792.63%
Total	417.31M	246.37M	158.96M	56.15M	13.10M
Total Growth	69.38%	54.99%	183.11%	328.73%	6792.63%

Source: S&P Global Market Intelligence.